BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 31538348)

  • 1. Prognostic significance of tumour budding assessed in gastric carcinoma according to the criteria of the International Tumour Budding Consensus Conference.
    Ulase D; Heckl S; Behrens HM; Krüger S; Röcken C
    Histopathology; 2020 Feb; 76(3):433-446. PubMed ID: 31538348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour budding in pancreatic cancer revisited: validation of the ITBCC scoring system.
    Karamitopoulou E; Wartenberg M; Zlobec I; Cibin S; Worni M; Gloor B; Lugli A
    Histopathology; 2018 Jul; 73(1):137-146. PubMed ID: 29495092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of tumour budding in stomach cancers.
    Kucuk S
    Int J Clin Pract; 2021 Dec; 75(12):e14922. PubMed ID: 34580963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-neoadjuvant assessment of tumour budding according to ITBCC subgroups delivers stage- and regression-grade independent prognostic information in intestinal-type gastric adenocarcinoma.
    Jesinghaus M; Herz AL; Kohlruss M; Silva M; Grass A; Lange S; Novotny A; Ott K; Schmidt T; Gaida M; Hapfelmeier A; Denkert C; Weichert W; Keller G
    J Pathol Clin Res; 2022 Sep; 8(5):448-457. PubMed ID: 35715937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Tumor Budding in Predicting Survival for Gastric Carcinoma Patients in Vietnam.
    Dao TV; Nguyen CV; Nguyen QT; Vu HTN; Phung HT; Bui OT; Nguyen DK; Luong BV; Tran TV
    Cancer Control; 2020; 27(1):1073274820968883. PubMed ID: 33136444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of tumor budding in gallbladder cancer: application of the International Tumor Budding Consensus Conference scoring system.
    Kim HN; Lee SY; Kim BH; Kim CY; Kim A; Kim H
    Virchows Arch; 2021 Jun; 478(6):1071-1078. PubMed ID: 33398430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should a fourth category be added to the international tumor budding consensus conference tumor budding scoring system in colorectal adenocarcinomas?
    Secinti IE; Ozgur T; Gursoy D; Dede I
    APMIS; 2022 Sep; 130(9):560-567. PubMed ID: 35816469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refining the ITBCC tumor budding scoring system with a "zero-budding" category in colorectal cancer.
    Zlobec I; Bächli M; Galuppini F; Berger MD; Dawson HE; Nagtegaal ID; Lugli A
    Virchows Arch; 2021 Dec; 479(6):1085-1090. PubMed ID: 33843013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic and predictive values of tumour budding in stage IV colorectal cancer.
    Nagata K; Shinto E; Yamadera M; Shiraishi T; Kajiwara Y; Okamoto K; Mochizuki S; Hase K; Kishi Y; Ueno H
    BJS Open; 2020 Aug; 4(4):693-703. PubMed ID: 32472647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Grading of tumor budding in intestinal-type early gastric adenocarcinoma and its role in assessing the risk of lymph node metastasis].
    Zhou ZY; Guo Q; Zhou ZH
    Zhonghua Bing Li Xue Za Zhi; 2021 Jul; 50(7):779-784. PubMed ID: 34405614
    [No Abstract]   [Full Text] [Related]  

  • 11. Increasing tumor budding in cholangiocarcinoma is associated with decreased disease-specific survival.
    Agostini-Vulaj D; Cates JMM; Bratton LE; Gonzalez RS
    Hum Pathol; 2021 May; 111():75-83. PubMed ID: 33727168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the International Tumor Budding Consensus Conference 2016 recommendations on tumor budding in stage I-IV colorectal cancer.
    Dawson H; Galuppini F; Träger P; Berger MD; Studer P; Brügger L; Zlobec I; Inderbitzin D; Lugli A
    Hum Pathol; 2019 Mar; 85():145-151. PubMed ID: 30428391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour budding in solid cancers.
    Lugli A; Zlobec I; Berger MD; Kirsch R; Nagtegaal ID
    Nat Rev Clin Oncol; 2021 Feb; 18(2):101-115. PubMed ID: 32901132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of peritumoural and intratumoural budding in intestinal-type gastric adenocarcinoma.
    Qi B; Liu L; Pan Y; Xu S; Li J
    Arab J Gastroenterol; 2020 Jun; 21(2):111-116. PubMed ID: 32423856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of tumour budding grade in 310 patients who underwent surgical resection for extrahepatic cholangiocarcinoma.
    Ogino M; Nakanishi Y; Mitsuhashi T; Hatanaka Y; Amano T; Marukawa K; Nitta T; Ueno T; Ono M; Kuwabara S; Yamada T; Hirano S
    Histopathology; 2019 May; 74(6):861-872. PubMed ID: 30667537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation and prognostic significance of tumor budding in pancreatic ductal adenocarcinomas.
    Argon A; Öz Ö; Kebat TA
    Indian J Pathol Microbiol; 2023; 66(1):38-43. PubMed ID: 36656208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR).
    Basile D; Broudin C; Emile JF; Falcoz A; Pagès F; Mineur L; Bennouna J; Louvet C; Artru P; Fratte S; Ghiringhelli F; André T; Derangère V; Vernerey D; Taieb J; Svrcek M;
    Ann Oncol; 2022 Jun; 33(6):628-637. PubMed ID: 35306156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Significance of Tumour Budding and Desmoplastic Reaction in Intestinal-Type Gastric Adenocarcinoma.
    Pun C; Luu S; Swallow C; Kirsch R; Conner JR
    Int J Surg Pathol; 2023 Sep; 31(6):957-966. PubMed ID: 35726174
    [No Abstract]   [Full Text] [Related]  

  • 19. Are tumour grade and tumour budding equivalent in colorectal cancer? A retrospective analysis of 771 patients.
    Zlobec I; Dawson HE; Blank A; Bokhorst JM; Berger MD; Nagtegaal ID; Lugli A
    Eur J Cancer; 2020 May; 130():139-145. PubMed ID: 32200222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Ability of Tumor Budding Outperforms Poorly Differentiated Clusters in Gastric Cancer.
    Szalai L; Jakab Á; Kocsmár I; Szirtes I; Kenessey I; Szijártó A; Schaff Z; Kiss A; Lotz G; Kocsmár É
    Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.